The Phage Consortium
We are a consortium of physicians and scientists promoting phage therapy as a response to the alarming global increase in infections with antibiotic resistant bacteria.
Since the foundation in 2020, there has been a close exchange between interdisciplinary EU phage experts in the Phage Consortium at regular monthly meetings and get-togethers at phage congresses. Here, a flat hierarchy, openness, as well as fast and uncomplicated communication are of great value to us.
As a result, we were able to advise patients in the EU on safe phage therapy and provide our expertise to patients and phage suppliers before, during, and after phage therapy. Aside, we found innovative solutions for phage applications of highest quality, and non-binding guidelines on safe phage therapy were published by the Phage Consortium.
In addition, we successfully connected phage experts in the EU, obtained EU-wide scientific grants, and issued peer-reviewed publications on translational scientific topics. Our educational short lectures train us on different phage-related aspects.
When regulatory conditions for phage therapy are particularly challenging, such as in Germany, regulatory efforts were encouraged in consultation with the Federal Institute for Drugs and Medical Devices (BfArM) and the respective state authorities in Germany.
All of these efforts can be continued thanks to our dedicated team members and generous funding, in order to potentially provide an answer to the globally increasing challenge of antibiotic resistance.
About this website
This site uses cookies. Using the site you agree to our terms, conditions, and data protection protocols.